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Summary 
Carcliocersion is a nzinor procedure requiring sedation and uiiulgesia. HobLwer, it is often pei;fornied out-of-hours in reniote sites 
hp inexperienced Nn(Itj.).tIit~ti.)t.s. An understanding is required both of' the pathoph?.siolog}. uizderlying cardiac arrh?~thniius rind 
of the technical side of' d<fihrillation equipment, including electrical .sqfelj,. Patients should huce their roagulation stutus und 
electrolyte balance checked prior to  the procedure to reduce the likelihood of'coniplications. Alnzost all the arailahle anaesthetic 
agents 1zac.e been used ,for cur-dioiwsion in the past,  with carying degrees of  success. The anaesthetic agent chosen f iw pntients 
undergoing curdiorersion must prooide unalgesia and sedation, cause the  leasi cardio~~asculau cotiipromise po.ssih1e and .still enable 
rapid recocer.v. Propofbl muj  he the closest anaesthetic agent to this itleal curreiztlj, a i d a b l e ,  although careful titrution of aiiy 
ugent chosen is also irnpor-tant. Cardioiwsion niuy he pecfi)rnied us an eniergency, including in the pregnant patient, proriding 
saf fe unaesthetic practice is ,followed. 
Key words 
Cardioi.ersion . 
Defihrilla t ion. 
Equipnimi; defibrillator. 
Direct current (DC) countershock is a method of convert- 
ing cardiac arrhythmias back to sinus rhythm. I t  involves 
the passage of electric current froin an external capacitor- 
discharge type defibrillator through the heart. I t  may be 
used in the emergency situation to terminate life-threatening 
cardiac arrhythmias or electively to stabilise abnormal 
rhythms with potential deleterious effects. Cardioversion is 
the electrical conversion of any rhythm other than 
ventricular fibrillation and involves synchronisation of the 
delivered shock with the R wave of the electrocardiograph 
(ECG). 
The earliest recorded successful resuscitation using 
electricity was performed in 1774 on a 3-year-old 
near-drowned child using a Leyden jar as the source [ I ] .  The 
treatment of ventricular fibrillation itself was investigated 
by Prevost and Batelli, who successfully defibrillated the 
hearts of animals in 1899 [2]. Alternating current (AC). first 
used in humans in 1947 [3], was thought to be the definitive 
method for defibrillation up until the 1960s. However, 
direct current (DC) shock. which was first used in man in 
1962 by Lown [4], was shown to be more effective than 
alternating current and also produced less skeletal muscle 
contraction with less risk of causing ventricular fibrillation 
both in the patient and the operator [5]. Since that time, 
improvements have been made in the shape of the DC 
current waveform [6], the timing of shock in relation to the 
onset of fibrillation [7] and more recently with the advent 
of automatic external defibrillators [8] and implantable 
defibrillators [9] capable of automatic rhythm recognition 
and management. 
Patients requiring elective cardioversion need sedation 
and analgesia as the procedure is painful and distressing 
[lo]. They may have significant pre-existing cardiac disease. 
including previous myocardial infarction, cardiac failure, 
angina and hypcrtension. as well as co-existing diseases of 
other organ spystems. Attention should be directed to these 
factors when considering a suitable anaesthetic technique. 
Patients for cardioversion are often anaesthetised in spare 
moments between operating theatre lists by junior 
anaesthetists in unfamiliar surroundings. The urgency of 
the situation may mean that anaesthesia must be induced 
in  a patient with a full stomach. 
This review details the mechanism of action of the 
defibrillator and the indications for direct current 
cardioversion. A review of the literature on anaesthesia for 
cardioversion follows and some guidelines are suggested for 
safe practice. 
Defibrillators, defibrillation and cardioversion 
Carctitrc pliysiologj, 
The cardiac rhythm is generated from the conducting 
system of the heart. consisting of the sino-atrial node. 
atrioventricular node and the right and left bundles of His. 
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Just as the heart responds to an intrinsic electrical impulse 
from the sino-atrial node. so it will respond to an extrinsic 
electric impulse. If enough electric current is delivered to the 
heart, the majority of myocardial cells are depolarised and 
contract. When the current is removed. if a critical mass of 
the myocardium is in the recovery phase of the cardiac 
cycle [l 11. defibrillation occurs and the sino-atrial node or 
other intrinsic pacemaker can regain control. This is the 
underlying principle of defibrillation or cardioversion. 
Principles of the &fibrillator [5. 121 
The electrical circuitry of a defibrillator is shown in 
Figure 1. A capacitor is used to store about 160 mC of 
current, which is discharged over a short period of time; 
3 nis is typical. A capacitor consists simply of two plates 
separated by an insulator. The inductor is included in the 
circuit to lengthen the current pause. 
When a defibrillator discharges, three factors determine 
the amount of energy delivered to the patient-the potential 
of the charge, the electrical current and the duration of 
current. 
Stored energy ( J )  = 
Potential difference ( V )  x Current ( A )  x Time (s) 
and, 
Current ( A )  = Charge (C) per second 
Therefore. 
Stored energy ( J )  = 
Potential difference ( V )  x Stored charge (C) 
i.e. E = CV 
Available energy is proportional to the product of the 
charge and the voltage which decreases from its initial peak. 
Thus the stored energy is, i n  fact, only half that calculated 
from the initial peak potential. 
For  5000 V potential, 160 mC of charge is produced, thus 
at  maximum output: 
Energy = x 160 mC x 5000 V = 400 J 
There is a further complicating factor. The energy stored 
by the defibrillator is not the same as the energy delivered 
to the patient. The latter depends upon the transthoracic 
impedence of the patient which is typically 50 ohms (O), 
1 
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Fig. 1. Electrical circuit arrangement in a typical defibrillator. 
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although this may vary depending on the inter-electrode 
distance. electrode-chest coupling medium (i.e. the gel), 
previous shocks, skin resistance, sweating and the phase 
of ventilation of the patient's lungs [13, 141. When 
defibrillators are tested, a test impedance of 50 0 is used. 
Some defibrillators indicate the actual energy delivered to 
the patient following discharge. 
The transthoracic impedance is standardised as much as 
possible between patients by using large paddles, applying 
conductive electrode gel to the skin and applying firm 
pressure. I t  is important to use the correct paddle position 
during cardioversion [ 151. Paddles should not be placed 
over the sternum because bone is a poor conductor, but 
should be placed antero-posteriorly or antero-laterally. No 
difference in likelihood of success has been shown between 
these two routes [16]. Paddle size is also important; large 
paddles reduce the impedance to current flow and reduce 
the possibility of myocardial damage. However, there is also 
a maximum size, to avoid the possibility of the paddles 
touching and to ensure that all the current passes through 
the heart [17]. 
The success of cardioversion has also been shown to be 
related to the phase of ventilation in which it is carried out. 
Electrical impedance is at its lowest when the thoracic 
volume is at a minimum. Thus cardioversioii should ideally 
be carried out during the expiratory phase of ventilation 
[13]. 
Electrical energy requiremxts  
In rhythms affecting the whole myocardiuin-ventricular 
tachycardia, for instance-a large current is used, starting 
with 200 J.  In atrial flutter or fibrillation, however, only the 
atria are affected. The current required is thus reduced and 
only 25-100 J may be necessary for effective cardioversion 
[18]. It has also been shown that successive shocks actually 
reduce the transthoracic impedance by a significant 
amount, up to 8% for the first shock [13]. This is a further 
reason why a second or subsequent shock may be successful 
when the first has failed. 
Much smaller quanta of energy are required during 
internal defibrillation which is performed when the chest is 
open, for example during cardiac surgery. I n  this case. the 
high electrical impedance of the lungs is removed and the 
optimum initial energy for internal defibrillation is only 10 
to 20 J [ 191. Larger shocks than this can produce myocardial 
necrosis. Paddles, handles and cables must, of course, be 
sterilised or autoclaved before use. 
Electrical sufetj> 
Defibrillators must conform to Type CF medical electrical 
equipment (labelled with the symbol m). This means that 
they are class I or I1 mains powered equipment with 
maximum patient leakage current of 10 pA in normal 
condition and 50 pA with a single-Pduit connection [20]. 
Class 1 Fquipment is earthed, class 11 is doubly-insulated 
and electrically isolated from ground. 
hidications , fbr curdiorersioti [ 15, 17, 2 11 (Table 1)  
There is a clear distinction between elective and emergency 
cardioversion. Emergency cardioversion (called defibrilla- 
tion if the underlying rhythm is ventricular fibrillation) is 
Table 1 .  Indications for elective cardioversion [ 15. 17, 211 





Arrhythmia< due to Wolff-Parkinson-White syndrome (atrial 
tachycardia. flutter or fibrillation) 
Atrial fibrillation 
1 .  Onset < 1 year 
2. Hihtory of systemic embolism 
3 .  Persistent after treated thyrotoxicosis or cardiac surgery 
4. Fast ventricular response, not controlled by drugs 
Supraventricular tachycardia when other therapy has failed 
commonly required for ventricular arrhythmias. although 
any cardiac arrhythmia which causes acute cardiovascular 
compromise, such as atrial fibrillation with a fast 
atrio-ventricular conduction rate, may require urgent 
cardioversion. Under these circumstances, the patient may 
have lost consciousness because of the poor cardiac output 
and anaesthesia or analgesia may not be necessary or 
desirable. 
Patients with limited cardiovascular compromise, but 
with rhythms which are unstable or which predispose to 
complications such as thrombus formation. require 
cardioversion, but in these cases it may be undertaken as an 
elective procedure. In practice. most of these rhythms are 
supraventricular in origin. The commonest indication for 
elective cardioversion is atrial fibrillation and cardioversion 
is successful in up to 90% of these patients although there 
is a high incidence of relapse [14. 221. The length of time 
that the patient has been in atrial fibrillation is the most 
important factor in determining the likelihood of success of 
the procedure [ 141. There are no absolute contraindications 
to cardioversion, although Table 2 lists some of the relative 
contraindications. 
Patients undergoing elective cardioversion require an 
anaesthetic as they are conscious and the procedure is 
painful [lo]. These cases may be delayed until the patient is 
fasted. thus removing some of the anaesthetic problems. 
S~,~c~hroni.c.ation 
Following cardiac contraction, there is a period of 
unresponsiveness to electrical stimulation called the 
refractory period. This may be further divided into the 
absolute refractory period, when no amount of stimulation 
can cause depolarisation and the relative refractory 
period. when supramaximal stimuli can cause depolaris- 
ation. The ventricular refractory period is represented by 
the T wave of the ECG. Depolarisation of the heart during 
the relative refractory period is associated with a high 
incidence of ventricular tibrillation. For this reason, this 
period of the cardiac cycle is known as the vulnerable 
period [I51 (Fig. 2). The risk of provoking ventricular 
fibrillation using a non-synchronised discharge is still less 
than 5 % .  
Table 2. Relative contraindications to elective cardioversion. 
Atrioventricular block 
Beta adrenoceptor blockade 
Abnormal clinical biochemical results ~ particularly hypokalaemia 
Digoxin toxicity 
Poorly controlled anticoagulation 
Atrial fibrillation with a slow ventricular response rate 
Fig. 2. The ‘Lulnerable period‘ of the ECG 
During cardioversion. it is clearly important to avoid 
precipitation of a more unstable rhythm than that already 
present. Thus for elective cardioversion, with a rhythm in 
which there are relatively normal QRS complexes on the 
ECG, the technique of synchronised D C  shock is used to 
minimise this risk. The defibrillator ‘marks’ an R wave by 
using criteria such as its steep slope and relatively large 
amplitude. When the defibrillator discharge button is 
pressed, the shock is not delivered until the next R wave is 
recognised by the machine. 
Anaesthesia for cardioversion 
Patient prepnration 
Cardioversion is frequently performed in areas where 
anaesthesia is rarely used, such as the coronary care unit. 
For this reason, it is essential that adequate staff, equipment 
and preparation are available for the procedure. This means 
a trained operating department assistant or anaesthetic 
nurse, an anaesthetic machine, an oxygen source, suction 
apparatus, a means of providing intermittent positive 
pressure ventilation as well as an anaesthetist with 
experience of cardioversion [23]. The anaesthetic machine 
and other equipment should be checked before use. 
Standard monitoring as recommended by the Association 
of Anaesthetists of Great Britain and Ireland should also be 
employed [24]. 
Some patients undergoing cardioversion will be anticoag- 
ulated to prevent systemic embolisation [25]. It is important 
to check that the degree of anticoagulation is adequate prior 
to the procedure. Similarly, current serum electrolyte values 
should be checked. Patients who are receiving glyceryl 
trinitrate patches for angina or cardiac failure should have 
these removed prior to cardioversion as there is a risk of an 
explosion with electric sparks. 
I t  would be unusual to premedicate patients for 
cardioversion routinely, although some authors have 
recommended the use of anticholinergic drugs such as 
atropine given immediately prior to anaesthesia to avoid the 
precipitation of vagotonic bradyarrhythmias during the 
procedure [26]. 
Choice of‘ irzduction agent 
The ideal anaesthetic agent for use in patients undergoing 
cardioversion should produce rapid loss of consciousness 
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with some analgesia, rapid recovery and should not 
accumulate on repeated dosing. It should be devoid of 
cardiovascular side-effects and in particular should have 
minimal effects on myocardial contractility and conduction. 
It should not cause vomiting or other side effects and should 
have a short elimination half-life. which is not prolonged in 
patients with renal or hepatic impairment. 
None of the anaesthetic agents currently available possess 
all of these qualities. However. all the intravenous induction 
and sedative agents have been tested, with various degrees 
of success. The first sedative agents used were benzo- 
diazepines, chosen because of their amnesic and sedative 
properties. Diazepam was the original drug used for 
sedation [27-291, having been shown to be relatively 
cardiovascularly stable in poor risk patients [30] and was 
associated with a lower incidence of ventricular extrasys- 
toles than thipentone [31]. However, in one study, one third 
of patients given diazepam were not amnesic for the 
procedure [32].  Diazepam has been largely superseded by 
midazolam, which has a shorter duration of action, 
produces less pain on injection and is associated with a 
lower incidence of allergic response [33, 341. Midazolam has 
been used with the benzodiazepine antagonist flumazenil to 
prevent residual sedation [35], although one study showed 
prolonged sedation with midazolam even after the patients 
had been given flumazenil [36]. Flunitrazepam has also been 
used [37] although there appears to be no particular reason 
why it should offer any advantage over midazolam. 
The barbiturates are another group of drugs used 
frequently for anaesthesia for short procedures. Thiopen- 
tone was, in fact, the sedative drug used by Lown in his 
original case report of DC cardioversion in humans [38]. 
Both thiopentone [36, 39-42] and methohexitone [43] have 
been successfully used for anaesthesia for cardioversion, 
producing rapid anaesthesia and recovery. Disadvantages 
of the barbiturates include the need for pre-mixing [43]; a 
greater degree of apnoea [32, 361; being subjectively less 
pleasant than propofol [41]; and a reduction in systolic 
arterial pressure. Lignocaine has been given with thiopen- 
tone in an attempt to reduce its cardiovascular depressant 
effects [44]. One other major disadvantage of the 
barbiturates is that they accumulate when given in repeated 
doses, so if the procedure is prolonged for any reason, 
second and subsequent doses may cause recovery to be 
prolonged. 
Etomidate is traditionally held to be an appropriate agent 
to use for patients with cardiovascular compromise, being 
cardiovascularly stable with a low incidence of allergic side 
effects. However, many anaesthetists avoid using it because 
of adverse effects on adrenal cortical steroid biosynthesis 
first highlighted in 1984 [45]. Etomidate has been used alone 
for cardioversion [39,40,46,47], or with fentanyl to 
provide analgesia [48]. However, it produces pain on 
injection in most patients, prolongs recovery compared with 
propofol [49], causes myoclonus on induction which may 
interfere with electrocardiographic interpretation 
[39, 46,47,49] and causes postoperative nausea and 
vomiting. These complications are in addition to the 
inhibitory effects of etomidate on the adrenal cortex. which 
may occur even after a single dose [50]. 
Propofol is probably the drug which most closely 
approaches the ideal agent for cardioversion 
[36, 41,47, 51, 521. I t  is formulated as a ready-to-use 
solution, is subjectively pleasant a t  induction, produces 
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rapid loss of consciousness and amnesia and may be given 
in repeated doses if the procedure takes longer than 
expected. without accumulation and prolongation of 
recovery. The incidence of pain on injection of propofol is 
low if it is pre-mixed with small amounts of lignocaine. The 
only major drawback of propofol is the decrease in blood 
pressure which accompanies bolus administration. This has 
been successfully combated by giving it as an infusion rather 
than by bolus injection [47]. 
Historically, other intravenous anaesthetic agents such as 
Althesin [S3] and propanidid [32] were used for anaesthesia 
for cardioversion in the past but have been withdrawn 
from use. Eltanolone (pregnanolone) is a new steroid-based 
anaesthetic agent which has some of the features of the ideal 
induction agent and may be suitable for cardioversion [S4]. 
Prr-oxj,genatioiz 
Pre-oxygenation for a period of several minutes is 
recommended for all patients undergoing cardioversion, not 
just those requiring rapid sequence induction. It provides a 
margin of safety if there are subsequent unexpected 
problems in ventilation or oxygenation and reduces the 
incidence of desaturation episodes in spontaneously-breath- 
ing patients following induction of anaesthesia [ 5 S ,  561. 
Cur-diocrrsion j &  the putieizt with a ,full stonwcli 
If cardioversion is required as a matter of extreme urgency 
it may be necessary to induce anaesthesia in a patient with 
a full stomach. Anaesthetic considerations regarding this 
outweigh considerations of convenience or unavailability of 
equipment. Measures must be taken to secure the airway 
against regurgitation and aspiration of gastric contents. 
This will involve pre-oxygenation, tracheal intubation and 
the use of depolarising muscle relaxants. Suxamethoniuni is 
not contraindicated in these patients, but bradyarrhythniias 
may be precipitated and hyperkalaemia exacerbated. The 
serum potassium level should be within normal limits. 
Cardiovasculur stahilitj' 
Whichever induction agent is chosen, careful titration of the 
drug should be used to avoid overdose. Some consideration 
should be given to the depth of anaesthesia required. The 
procedure is stimulating and painful, therefore sufficient 
anaesthetic depth must be reached to avoid a sympathetic 
hypertensive response which could be harmful. Suitable end 
points for induction are loss of verbal contact or eyelash 
reflex. 
The most dangerous side effect of the anaesthetic 
induction agents in cardioversion is their ability to cause 
depression of an already dysfunctional cardiovascular 
system. Etoniidate may be the safest agent in this respect, 
but it has other deleterious effects. Infusions of anaesthetic 
drugs have been used and shown to produce less 
cardiovascular depression than bolus doses [47]. 
Rec0cc.r-j. 
After restoration of normal sinus rhythm, rapid return to 
full consciousness with recovery of normal airway reflexes 
is desirable. Patients undergoing cardioversion are rarely 
adjacent to the usual recovery areas and are frequently 
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recovered in the place where they were anaesthetised. 
Despite this, facilities for suction and oxygen adminis- 
tration and a full range of emergency drugs should be 
immediately available. A trained nurse must stay with the 
patient until recovery is complete. 
Cardiocersion in prtlgnancj, 
This has been reported by several authors [57-591 and has 
been shown to be safe for the mother and baby,  although 
it has led to fetal arrhythmias [60]. These cases present the 
combined problems of anaesthesia in a pregnant woman 
and the use of anaesthetic drugs in a patient with a 
compromised circulation. 
Complications of cardioversion 
Most anaesthetic complications following elective car- 
dioversion are related to cardiovascular depression. Air- 
way complications are rare since tracheal intubation and 
the use of suxamethonium are uncommon. However, any 
anaesthetic complication may follow anaesthesia for 
cardioversion. Many other complications have been 
described, including ventricular fibrillation [61], death due 
to synchronisation failure of a defibrillator [62], elevation of 
cardiac enzyme levels [63] (although this is mainly from 
skeletal muscle damage [64]), rhabdomyolysis and renal 
failure [65], systemic embolisation [66, 671 and severe 
bradycardia [68]. It is advisable for the anaesthetist to 
remove the oxygen source from the patient prior to  
cardioversion or defibrillation as there have been reports of 
burns occurring to patients when oxygen has been left 
running in the close vicinity of the patient. A hazard 
warning was issued concerning this [69]. 
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